Johnson & Johnson JNJ
271.22
0.54
0.20%
as of 25 Sep
- Market cap
- $652.8B
- P/E
- 31.4×
Follow JNJ
S&P 500 Member
Dividend Aristocrat
Cash Flow Champion (3y)
Revenue Champion (3y)
Insider Buys (last 12m)
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Johnson & Johnson (JNJ) Revenue growth
Johnson & Johnson's revenue growth over the twelve months to 30 June 2026 was 8.06%, up 2.0 percentage points from fiscal 2025 (6.05%). Over the past ten years it has ranged from −5.73% (fiscal 2015) to 6.71% (fiscal 2018); the current reading is higher than 73% of that period. That is above the Drug Manufacturers General industry median of 6.79% and in line with the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 6.05% | 1.75 |
| FY2024 | 4.30% | (2.16) |
| FY2023 | 6.46% | 4.87 |
| FY2022 | 1.59% | 6.24 |
| FY2021 | −4.65% | (5.29) |
| FY2020 | 0.64% | 0.05 |
| FY2019 | 0.59% | (6.12) |
| FY2018 | 6.71% | 0.37 |
| FY2017 | 6.34% | 3.75 |
| FY2016 | 2.59% | 8.32 |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 6.60% | (3.31) |
| Mar 2026 | 9.91% | 0.83 |
| Dec 2025 | 9.08% | 2.31 |
| Sep 2025 | 6.77% | 1.00 |
| 42 more quarters | Free account |
Against its own ten years
Low −5.73%
High 6.71%
Ten-year median
2.59%
Current reading's percentile
73
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| LLY Eli Lilly and Company compare | 49.6% |
| ABBV AbbVie Inc. compare | 10.4% |
| AMGN Amgen Inc. compare | 9.10% |
| AZN AstraZeneca PLC compare | 8.61% |
| JNJ Johnson & Johnson | 8.06% |
| GILD Gilead Sciences, Inc. compare | 5.52% |
| MRK Merck & Co., Inc. compare | 4.64% |
| NVS Novartis AG compare | 2.73% |
| PFE Pfizer Inc. compare | −0.21% |
| Drug Manufacturers General industry median | 6.79% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on JNJ
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement